RecruitingChronic Kidney DiseasesEnd Stage Renal DiseaseArteriovenous Fistula
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Eligible age
18+ yrs
Accepts
All genders
Locations
13 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a new arteriovenous fistula (AVF) in order to assess the safety and effectiveness of SelfWrap, a bioabsorbable perivascular wrap.
Sponsor: VenoStent
You may qualify if…
- ✓ Age of at least 18 years
- ✓ Referred for creation of a new AVF
- ✓ Willing and able to comply with study requirements, communicate with the study team, and attend follow up visits over a period of 36 months
You may not qualify if…
- ✕ Planned index procedure to revise or repair an existing fistula
- ✕ Target artery inner diameter \< 2.0 mm, as measured by ultrasound while the target arm is under tourniquet pressure and anesthesia
- ✕ Target vein inner diameter \< 2.0 mm, as measured by ultrasound while the target arm is under tourniquet pressure and anesthesia
- ✕ Significant (at least 50%) stenosis at the target vein on the side of surgery (between the planned anastomosis site and the axillary vein), as diagnosed by preoperative ultrasound
- ✕ Known central venous stenosis of at least 50% on the side of surgery
- ✕ Presence of a stent or a stent graft within the access circuit
- ✕ Known or suspected coagulation disorder that, in the opinion of the Investigator, puts too much risk on the patient for AVF creation
- ✕ Known or suspected active infection at the time of surgery
Where it's recruiting
Arizona
Bullhead City · Marana · Phoenix · Tucson
California
Garden Grove
Florida
Tallahassee
Indiana
Fort Wayne
Kentucky
Lexington
Massachusetts
Boston
Minnesota
Rochester
Missouri
Columbia · St Louis
New York
Lake Success
North Carolina
Charlotte · Raleigh
South Carolina
Charleston · Columbia · Florence · Greenville …
Tennessee
Memphis
Source: ClinicalTrials.gov · NCT06001827 · last updated 2026-02-17